Market openNon-fractional

DiaMedica Therapeutics Inc. Common Stock/DMAC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About DiaMedica Therapeutics Inc. Common Stock

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Ticker

DMAC

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Minneapolis, United States

Employees

19

DMAC Metrics

BasicAdvanced
$149M
Market cap
-
P/E ratio
-$0.54
EPS
1.73
Beta
-
Dividend rate
$149M
1.73
18.144
17.927
0.634
0.82
-33.79%
-52.50%
2.84
2.84
-6.088
-6.93%
-11.69%

What the Analysts think about DMAC

Analyst Ratings

Majority rating from 3 analysts.
Buy

DMAC Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$5.1M
-0.00%
Profit margin
0.00%
NaN%

DMAC Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.64%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.16
-$0.12
-$0.14
-$0.14
-
Expected
-$0.18
-$0.13
-$0.14
-$0.16
-$0.16
Surprise
-9.43%
-5.26%
0.00%
-10.64%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DiaMedica Therapeutics Inc. Common Stock stock?

DiaMedica Therapeutics Inc. Common Stock (DMAC) has a market cap of $149M as of July 23, 2024.

What is the P/E ratio for DiaMedica Therapeutics Inc. Common Stock stock?

The price to earnings (P/E) ratio for DiaMedica Therapeutics Inc. Common Stock (DMAC) stock is 0 as of July 23, 2024.

Does DiaMedica Therapeutics Inc. Common Stock stock pay dividends?

No, DiaMedica Therapeutics Inc. Common Stock (DMAC) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next DiaMedica Therapeutics Inc. Common Stock dividend payment date?

DiaMedica Therapeutics Inc. Common Stock (DMAC) stock does not pay dividends to its shareholders.

What is the beta indicator for DiaMedica Therapeutics Inc. Common Stock?

DiaMedica Therapeutics Inc. Common Stock (DMAC) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell DiaMedica Therapeutics Inc. Common Stock stock

Buy or sell DiaMedica Therapeutics Inc. Common Stock stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing